Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
